CoChat

Aberrations of p16Ink4 and retinoblastoma tumour‐suppressor genes occur in distinct sub‐sets of human cancer cell lines

Aagaard, Louise, Lukas, Jiri, Bartkova, Jirina, Kjerulff, Anne‐Arnt, Strauss, Michael, Bartek, Jiri · 1995 · International Journal of Cancer
Cited by 102

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

The p16 Ink4/MTSI/CDKN2 is a cell‐cycle regulatory inhibitor of cyclin‐dependent kinase 4 (cdk4), and a candidate tumour suppressor whose gene on chromosome band 9p21 is frequently deleted or mutated in diverse types of cancer. Cdk4 in association with its D‐type cyclin partners, together with p16 Ink4, and the product of the retinoblastoma tumour‐suppressor gene (pRB), appear to constitute a G 1‐phase‐controlling pathway which can become de‐regulated through oncogenic aberrations of any of the components. In an attempt to elucidate the underlying molecular mechanisms, we have now surveyed expression of p16 Ink4, at the protein and the mRNA levels, in 21 human cell types expressing normal pRB, as compared with another series of 21 cell lines whose pRB is mutant and/or inactivated through sequestration by DNA tumour virus onco‐proteins. In contrast to aberrant lack of p16 expression in the majority of RB‐positive cell types, expression of apparently normal (as shown by electrophoretic mobility and/or the ability to form protein‐protein complexes with cdk4 in vivo) p16 was uniformly preserved in the cancer cell lines whose RB function was compromised. These data indicate that p16 operates upstream of pRB along the same pathway in G 1. The results are discussed in view of the nature of a selective growth advantage potentially gained by cells through de‐regulation of this key cell‐cycle control mechanism. © 1995 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.2910610120

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 102

Metadata

Authors
Aagaard, L., Lukas, J., Bartkova, J., Kjerulff, A., Strauss, M., & Bartek, J.
Venue
International Journal of Cancer
Publisher
Wiley
Published
1995-03-29
Volume
61
Issue
1
Pages
115-120
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W2040189858
Cited by
102
References
6
FWCI
4.86
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Aberrations of p16Ink4 and retinoblastoma tumour‐suppressor genes occur in distinct sub‐sets of human cancer cell lines. https://app.cochat.ai/papers/10.1002/ijc.2910610120
The paper
Aagaard, L., Lukas, J., Bartkova, J., Kjerulff, A., Strauss, M., & Bartek, J. (1995). Aberrations of p16Ink4 and retinoblastoma tumour‐suppressor genes occur in distinct sub‐sets of human cancer cell lines. International Journal of Cancer. https://doi.org/10.1002/ijc.2910610120

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.